Effects of Foot Muscle Strengthening in Daily Activity in Diabetic Neuropathic Patients
- Conditions
- Diabetic Neuropathies
- Interventions
- Other: Intervention Group
- Registration Number
- NCT02790931
- Lead Sponsor
- University of Sao Paulo General Hospital
- Brief Summary
The main objective of this trial is to investigate the effects of foot muscle strengthening in daily activity of patients with diabetic neuropathy.
- Detailed Description
A randomized controlled trial will be performed with 77 patients with diabetic neuropathy. The participants will be randomly assigned into either a control group (recommended foot care by international consensus with no exercises) or an intervention group which will receive 12-week physical therapy exercises, twice a week, under the supervision of a physiotherapist, and twice a week being remotely supervised by a software at home. Every exercise has its own progression depending on the subjects' execution, increasing in intensity and difficulty.
The subjects will be evaluated in 5 different moments (Baseline, 6 weeks, 12 weeks, 24 weeks and 1 year follow-up)
The hypothesis of this study is that the intervention group will increase daily activity levels, increase self-selected and rapid walking speed, reduce the incidence of plantar ulcers, increase foot health and functionality, improve symptoms, increase tactile and vibration sensitivity, increased passive range of motion, improved quality of life, increased isometric strength of the feet and production of beneficial biomechanical changes during walking compared to the control group after 12 weeks of intervention and follow-up year.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 78
- Diabetes mellitus type 1 or 2
- Moderate or severe polyneuropathy confirmed with the fuzzy software
- Ability to walk independently in the laboratory
- Accessibility to electronic devices
- Loss of at least 4 degrees of ankle range of motion
- Loss of at least 1 degree of force in the clinical scale of the plantar interosseous or lumbrical muscles
- Ulceration not healed for at least 6 months
- Hallux amputation or total amputation of the foot
- Receiving any physiotherapy intervention or offloading devices
- Neurological or orthopedic impairments
- Major vascular complications
- Severe retinopathy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Group Intervention Group Patients will receive a physical therapy intervention in groups twice/wk, and using a software twice/ wk for 3 months.
- Primary Outcome Measures
Name Time Method Daily Physical Activity 12 weeks Calculate the number of steps per week
Self Selected Gait Speed 12 weeks self selected gait speed shod walking velocity in a walkway
Fast Gait Speed 12 weeks Fast gait speed shod walking velocity in a walkway
- Secondary Outcome Measures
Name Time Method Foot and Ankle Kinematics During Gait baseline, 12 weeks Foot joints and plantar arch motion, ankle range of motion, and maximum ankle extension and flexion during gait
Plantar Ulcers 12 months New cases of foot plantar ulcers
Tactile Sensitivity 12 weeks Evaluation of the tactile sensitivity of four plantar areas with 10g monofilament
Range of Motion 12 weeks Manual goniometry of the range of motion of flexion and extension of the metatarsophalangeal joint of the hallux and ankle.
Risk Classification of Plantar Ulceration 12 weeks Score of the classification of the plantar ulcer risk (IWG diabetic foot)
Foot Health and Functionality 12 weeks Score of the Foot Health Status questionnaire - BRAZIL
Foot Strength 12 weeks Hallux and lesser toes force measured by a pressure plate
Ankle and Knee Joint Moments and Power During Gait baseline, 12 weeks Peak joint moment and eccentric and concentric power by inverse dynamic calculations
Vibration Sensitivity 12 weeks Evaluation of the vibration sensitivity with tuning fork
Neuropathy Symptoms 12 weeks Score of the Michigan Neuropathy Screening Instrument questionnaire Michigan Neuropathy Screening Instrument (MNSI)
EQ-5D Score 12 weeks EQ-5D score of the quality of life of the patient
Trial Locations
- Locations (1)
Universidade de São Paulo
🇧🇷São Paulo, Brazil